Oncology Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . The Oncology Institute
TOIIW Stock  USD 0.14  0.01  6.67%   
Oncology Institute's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Oncology Institute's valuation are provided below:
Gross Profit
68.3 M
Profit Margin
(0.14)
Revenue
461 M
Earnings Share
(602.09)
Quarterly Revenue Growth
0.367
There are over one hundred nineteen available trending fundamental ratios for The Oncology Institute, which can be analyzed over time and compared to other ratios. All traders should should check out Oncology Institute's recent fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable. Market Cap is likely to drop to about 25.3 M in 2026. Enterprise Value is likely to drop to about 105.6 M in 2026

Oncology Institute Total Revenue

256.02 Million

Check Oncology Institute financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncology Institute's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 4.3 M or Interest Expense of 9.1 M, as well as many indicators such as Price To Sales Ratio of 0.0644, Dividend Yield of 0.0105 or PTB Ratio of 9.87. Oncology financial statements analysis is a perfect complement when working with Oncology Institute Valuation or Volatility modules.
  
Build AI portfolio with Oncology Stock
Check out the analysis of Oncology Institute Correlation against competitors.
For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.

Oncology Institute Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding76 M86.3 M68.3 M
Slightly volatile
Total Assets178.2 M198.6 M110.9 M
Slightly volatile
Other Current Liabilities12.3 M18.8 M8 M
Slightly volatile
Total Current Liabilities34.6 M60 M23.9 M
Slightly volatile
Total Stockholder Equity3.1 M3.2 M43.8 M
Pretty Stable
Property Plant And Equipment Net21.7 M43.3 M11.6 M
Slightly volatile
Accounts Payable15.6 M28 M12.3 M
Slightly volatile
Cash40.3 M57.1 M20 M
Slightly volatile
Non Current Assets Total69.7 M69.3 M50.5 M
Slightly volatile
Non Currrent Assets Other397.3 K677.4 K242.5 K
Slightly volatile
Cash And Short Term Investments60.3 M57.1 M27.6 M
Slightly volatile
Net Receivables34 M56 M24 M
Slightly volatile
Good Will12.1 M6.5 M13.9 M
Pretty Stable
Liabilities And Stockholders Equity178.2 M198.6 M110.9 M
Slightly volatile
Non Current Liabilities Total78 M134.4 M39.5 M
Slightly volatile
Inventory8.7 M11.5 M6.1 M
Slightly volatile
Other Current Assets5.5 M4.6 M2.7 M
Slightly volatile
Other Stockholder Equity141.5 M246.6 M68.3 M
Slightly volatile
Total Liabilities112.6 M194.5 M63.3 M
Slightly volatile
Property Plant And Equipment Gross53.9 M51.3 M15.1 M
Slightly volatile
Total Current Assets108.5 M129.3 M60.3 M
Slightly volatile
Capital Stock6.8 K7.2 K33 M
Slightly volatile
Non Current Liabilities Other106.9 K112.5 K991 K
Very volatile
Net Working Capital73.9 M69.2 M36.5 M
Slightly volatile
Intangible Assets14.7 M13.3 M19.8 M
Slightly volatile
Common Stock6.7 K9.2 K3.4 K
Slightly volatile
Short and Long Term Debt Total79.9 M141.6 M41.4 M
Slightly volatile
Current Deferred Revenue5.7 M5.4 M3.2 M
Very volatile
Long Term Debt73.5 M107.1 M34.9 M
Slightly volatile
Short and Long Term Debt156.5 K164.7 K3.5 M
Slightly volatile
Short Term Debt5.3 M7.8 M5.4 M
Pretty Stable

Oncology Institute Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization4.3 M7.2 M2.8 M
Slightly volatile
Interest Expense9.1 M8.6 M2.2 M
Slightly volatile
Selling General Administrative74.9 M124 M49.3 M
Slightly volatile
Total Revenue256 M452.4 M190.8 M
Slightly volatile
Gross Profit47.1 M62.1 M36.4 M
Slightly volatile
Other Operating Expenses298.6 M521.6 M211 M
Slightly volatile
Cost Of Revenue208.9 M390.3 M154.3 M
Slightly volatile
Total Operating Expenses89.7 M131.2 M56.7 M
Slightly volatile
Reconciled Depreciation4.2 M7.2 M2.8 M
Slightly volatile
Selling And Marketing Expenses33.3 M37.4 M40.9 M
Slightly volatile

Oncology Institute Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow26.9 M38.5 M13.9 M
Slightly volatile
Depreciation4.3 M7.2 M2.8 M
Slightly volatile
Capital Expenditures3.1 M4.4 M1.9 M
Slightly volatile
End Period Cash Flow34.7 M57.1 M18.4 M
Slightly volatile
Stock Based Compensation14.9 M12.8 M6.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.06440.06783.6152
Slightly volatile
Dividend Yield0.01050.01180.0129
Slightly volatile
PTB Ratio9.877.4312.0207
Slightly volatile
Days Sales Outstanding34.4440.6537.9336
Slightly volatile
Book Value Per Share0.05220.0550.66
Pretty Stable
Average Payables8.6 M9.7 M10.6 M
Slightly volatile
Stock Based Compensation To Revenue0.04590.04940.026
Slightly volatile
Capex To Depreciation0.570.540.6542
Pretty Stable
PB Ratio9.877.4312.0207
Slightly volatile
EV To Sales0.270.282.8528
Slightly volatile
Inventory Turnover30.5938.8830.9804
Pretty Stable
Days Of Inventory On Hand11.059.7212.0869
Slightly volatile
Payables Turnover12.0212.5614.2234
Very volatile
Sales General And Administrative To Revenue0.00130.00150.0016
Slightly volatile
Capex To Revenue0.00930.00870.0087
Slightly volatile
Cash Per Share0.620.60.3662
Slightly volatile
Payout Ratio1.661.872.0404
Slightly volatile
Days Payables Outstanding28.3530.0826.2181
Very volatile
Intangibles To Total Assets0.140.150.4402
Slightly volatile
Current Ratio2.461.942.1951
Slightly volatile
Receivables Turnover9.699.299.809
Slightly volatile
Shareholders Equity Per Share0.05220.0550.66
Pretty Stable
Debt To Equity32.4330.886.1925
Slightly volatile
Capex Per Share0.03250.04540.0264
Slightly volatile
Average Receivables12.8 M14.4 M15.7 M
Slightly volatile
Revenue Per Share2.694.722.6452
Slightly volatile
Interest Debt Per Share1.651.570.4961
Slightly volatile
Debt To Assets0.670.640.2945
Slightly volatile
Graham Number0.220.250.2764
Slightly volatile
Operating Cycle45.550.3650.0205
Slightly volatile
Price Book Value Ratio9.877.4312.0207
Slightly volatile
Days Of Payables Outstanding28.3530.0826.2181
Very volatile
Dividend Payout Ratio1.661.872.0404
Slightly volatile
Ebt Per Ebit0.981.240.9746
Very volatile
Company Equity Multiplier45.4843.319.4762
Slightly volatile
Long Term Debt To Capitalization0.910.870.3659
Slightly volatile
Total Debt To Capitalization0.920.870.4227
Slightly volatile
Debt Equity Ratio32.4330.886.1925
Slightly volatile
Quick Ratio2.261.761.9299
Slightly volatile
Cash Ratio0.880.860.5865
Slightly volatile
Cash Conversion Cycle24.8726.8224.6412
Slightly volatile
Days Of Inventory Outstanding11.059.7212.0869
Slightly volatile
Days Of Sales Outstanding34.4440.6537.9336
Slightly volatile
Price To Book Ratio9.877.4312.0207
Slightly volatile
Fixed Asset Turnover11.4112.0169.9518
Slightly volatile
Debt Ratio0.670.640.2945
Slightly volatile
Price Sales Ratio0.06440.06783.6152
Slightly volatile
Asset Turnover2.072.622.3202
Slightly volatile
Gross Profit Margin0.210.160.2105
Slightly volatile
Price Fair Value9.877.4312.0207
Slightly volatile

Oncology Institute Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap25.3 M26.7 M463.6 M
Slightly volatile
Enterprise Value105.6 M111.2 M480.4 M
Slightly volatile

Oncology Fundamental Market Drivers

About Oncology Institute Financial Statements

Oncology Institute investors use historical fundamental indicators, such as Oncology Institute's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Oncology Institute. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue5.4 M5.7 M
Total Revenue452.4 M256 M
Cost Of Revenue390.3 M208.9 M
Stock Based Compensation To Revenue 0.05  0.05 
Capex To Revenue 0.01  0.01 
Revenue Per Share 4.72  2.69 
Ebit Per Revenue(0.15)(0.18)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft

Additional Tools for Oncology Stock Analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY